Explore
← New search
4 matching publication(s)
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · Cell Rep Med · 2024
L1
72/100
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs.
PMID 38781959 · Cell Rep Med · 2024
L1
76/100
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.
PMID 35028613 · Cell Rep Med · 2021
L1
75/100
Contribution of retrotransposition to developmental disorders.
PMID 31604926 · Nat Commun · 2019
L1
79/100